Company Filing History:
Years Active: 2006-2010
Title: Volker Doersam: Innovative Mind Behind Arterial Thrombosis Research
Introduction
Volker Doersam, an accomplished inventor based in Marburg, Germany, has made significant contributions to the field of medical research, specifically concerning arterial thrombosis. With a total of two patents to his name, Doersam's work centers around the identification and detection of risk factors linked to this serious health concern.
Latest Patents
Doersam's latest patents focus on the Marburg I mutant of factor VII activating protease (FSAP) as a risk factor for arterial thrombosis. His first patent describes diagnostic determination methods aimed at detecting FSAP and its mutations, which may serve as indicators of an individual's risk of developing arterial thrombosis. The second patent delves deeper into this innovative concept, outlining a novel arterial thrombosis risk factor that includes one or more identified mutants of FSAP, along with methods for their detection. These groundbreaking patents highlight the relevance of his research in improving diagnostic techniques and potentially informing treatment strategies.
Career Highlights
Throughout his career, Volker Doersam has worked with notable companies in the biotechnology and medical fields, including Aventis Behring GmbH and CSL Behring GmbH. His experience in these organizations has provided him with valuable insights and resources to pursue innovative research that can have a meaningful impact on health care.
Collaborations
In addition to his individual accomplishments, Doersam has collaborated with esteemed researchers like Stefan Kiechl and Johann Willeit. These partnerships not only enhance the quality of his work but also strengthen the connections within the research community focused on vascular health and related conditions.
Conclusion
Volker Doersam is a distinguished inventor whose work has the potential to reshape the landscape of arterial thrombosis diagnostics and risk assessment. His innovative patents and collaborations underscore the importance of advancing medical technologies for better patient outcomes. Through his contributions, Doersam continues to pave the way for future research and innovation in the field.